Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - GROSS PROFIT
Gross Profit FATE - Fate Therapeutics, Inc.
-98.2 M
LAST VALUE
-72.15%
2 YEAR CAGR
-13.87%
5 YEAR CAGR
-24.43%
10 YEAR CAGR